Name
DRONCIT 50 MG TABLETS FOR DOGS AND CATS
Pharmacotherapeutic Group
Anthelmintics.
Active Ingredients
One 660 mg tablet contains the active substance: praziquantel 50 mg.
Excipients
Lactose, microcrystalline cellulose, polyvinylpyrrolidone, sodium lauryl sulphate, magnesium stearate, colloidal anhydrous silica, maize starch.
Indications
Anthelmintic for dogs and cats, with a specific effect against adult cestodes and immature intestinal forms. It is effective against: Echinococcus granulosus*, Echinococcus multilocularis, Dipylidium caninum, Taenia ovis, Taenia pisiformis, Taenia hydatigena, Mesocestoides corti, Hydatigera (Taenia) taeniaeformis, Taenia multiceps, Diphyllobothrium (Spirometra) erinacei. * Echinococcus granulosus: the dog, a carrier of the echinococcus tapeworm, becomes infested via sheep, cattle or pigs and can also transmit echinococcosis (hydatidosis, cystic form) to humans, a serious social disease in sheep-farming regions. Therapeutic and/or prophylactic treatment with the veterinary medicinal product (ideally planned on a large scale) interrupts the parasite's biological cycle and prevents transmission to humans. Hydatidosis cycle.
Contraindications/Side Effects
Do not use in cases of hypersensitivity to the active substance or to any of the excipients. Do not use in dogs weighing less than 2.5 kg.
Safety in Target Species
None known.
Dosage
For oral use. The basic dose for dogs and cats is 5 mg/kg bw. Therefore: 1 tablet up to 10 kg bw. 2 " from 11 to 20 kg. 3 " from 21 to 30 kg. Against Diphyllobothrium (Spirometra) a dose of one tablet per 2.5 kg bw is required. Overdoses of up to twice the recommended dose are not harmful, especially when treating massive echinococcus tapeworm infestations. The veterinary medicinal product is very well tolerated. In adult animals, doses of up to 10 times the recommended dose (5 mg/kg bw) are generally well tolerated. Underdosing could result in ineffective use and may favour the development of resistance. The accuracy of the dose must be carefully checked. Treatment should be given on an empty stomach, and animals should be observed immediately after administration so that treatment can be repeated if the tablets are rejected. The veterinary medicinal product can be given directly, wrapped in meat or crushed into food.
Storage
This veterinary medicinal product does not require any special storage conditions. Shelf life of the veterinary medicinal product as packaged for sale: 5 years.
Warnings
Fleas act as intermediate hosts and are therefore a source of Dipylidium caninum infection. To avoid reinfection, fleas must be eliminated from the animal and its living quarters. Faeces passed by dogs in the 24 hours following treatment must be collected and destroyed. The possibility that other animals in the same environment may be a source of reinfection with Dipylidium caninum should be considered, and these should be treated as necessary with an appropriate product. Unnecessary use of antiparasitics or use deviating from the instructions given in the SPC may increase the resistance selection pressure and lead to reduced efficacy. The decision to use the product should be based on confirmation of the parasitic species and burden, or of the risk of infection based on its epidemiological features, for each animal. Special precautions for safe use in the target species: none. Special precautions to be taken by the person administering the veterinary medicinal product to animals: for proper hygiene, the person administering the product should wash their hands after use. In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the doctor. Special precautions for the protection of the environment: not applicable. None known. Incompatibilities: none known.
Withdrawal Period
Not applicable.
Target Species
Dog and cat.
Interactions
None known.
Diagnosis and Prescription
Veterinary medicinal product not subject to veterinary prescription.
Side Effects
Dogs and cats. Very rare (<1 animal / 10,000 animals treated, including isolated reports): digestive tract disorders (e.g. vomiting or diarrhoea). Reporting adverse events is important as it allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to the marketing authorisation holder or its local representative or to the national competent authority via the national reporting system https://www.salute.gov.it/portale/moduliServizi/dettaglioSchedaModuliServizi.jsp? lingua=italiano&label=servizionline&idMat=MDV&idAmb=FMV&idSrv=PSK&flag=P. See also section 16 of the package leaflet for the respective contact details.
Pregnancy and Lactation
Pregnancy and lactation: the veterinary medicinal product can be used in dogs and cats during pregnancy. Praziquantel is considered safe for both the female animal and the foetus. The safety of the veterinary medicinal product during lactation has not been established. Use only according to the benefit-risk assessment by the responsible veterinarian.
